ProVaHealth aims to overcome the following challenges:
- Most Living Lab infrastructure serves only locally or regionally meaning lack of clients
- Slow market uptake of innovations
The overall strategic aim is the “Baltic Sea Region as one test site for development of healthcare products and services”.
ProVaHealth facilitates access to health infrastructures for startups and SMEs aiming for commercialization with excellent client validation opportunities, hands-on feedback and input for product development.
It involves 14 health Living Labs from the Baltic Sea Region.
- Partners: 17 organisations from 8 Baltic Sea countries
- Duration: 36 months (2017 – 2020)
- Total budget: 3,022,842 €
- ERDF co-financing 2,353,386 €
- Fund: Interreg Baltic Sea Region Programme 2014-2020
- Part of the flagship “HealthRegion” recognized by the EU strategy for the Baltic Sea Region, Policy Area Innovation
- Lead Partner: Tallinn Science Park Tehnopol
- To create better collaboration between Health Living Labs in the Baltic Sea Region
- To ensure smooth access to Living Lab services for SMEs
- To improve market uptake of new products and services in health
- Enforcing innovation, creation of new entreprises and growth of SMEs
- Improving peoples health, well-being and quality of life
- Bring service to 300 SMEs
- Open services of Living Labs promoted globally
- Self-evaluation toolbox for Living Labs
- Transnational Living Lab concept including a service model
- Long-term business plans for 14 Living Labs
- 14 SMEs have a product and/or service validated